Publication: Comparative plasma protein profiling of hemoglobin H disease
Accepted Date
2014-05-29
Issued Date
2014
Resource Type
Language
eng
Rights
Mahidol University
Bibliographic Citation
Disease Markers. 2014, ID 340214
Suggested Citation
Kamonlak Leecharoenkiat, Wannapa Sornjai, Kornpat Khungwanmaythawee, Atchara Paemanee, Chartchai Chaichana, Sittiruk Roytrakul, Suthat Fucharoen, Saovaros Svasti, Smith, Duncan R. Comparative plasma protein profiling of hemoglobin H disease. Disease Markers. 2014, ID 340214. doi:10.1155/2014/340214 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/1844
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Comparative plasma protein profiling of hemoglobin H disease
Other Contributor(s)
Abstract
HbH and HbH-constant spring (HbH-CS) are the most common forms of α-thalassemia detected in the Thai population. The accumulation of excess β globin chains in these diseases results in increased red cell hemolysis, and patients with HbH-CS normally have a more severe clinical presentation than patients with HbH disease. This study aimed to detect alterations in the expression of plasma proteins of HbH and HbH-CS patients as compared to normal plasma. Platelet poor plasma was separated from HbH and HbH-CS and normal subjects and differential plasma proteins were detected using two-dimensional gel electrophoresis and identified using LC/MS/MS. A total of 14 differentially expressed proteins were detected of which 5 proteins were upregulated and 9 were downregulated. Most of the differentially expressed proteins are liver secreted proteins involved in hemolysis, oxidative stress response, and hemoglobin degradation. Seven proteins were found to be differentially expressed between HbH and HbH-CS. Levels of haptoglobin, a hemoglobin scavenging protein, were significantly increased in HbH patients as compared to HbH-CS patients. The identification of differentially expressed proteins may lead to a better understanding of the biological events underlying the clinical presentation of HbH and HbH-CS patients and can have application as hemolytic markers or severity predictors.